Company Humorigin Biotechnology Corp

Equities

6487

TW0006487002

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 03:30:00 26/07/2018 am IST			5-day change	1st Jan Change
4.05 ^TWD	+3.85%		-22.86%	-.--%

HumOrigin Biotechnology Inc. is a Taiwan-based company principally engaged in the research and development of new drugs. The Companyâs main products include new monoclonal antibody drugs for the immunotherapy of cancers, new anti-influenza drugs and immune cells. The Company also provides related commissioned design services. The Company distributes its products in domestic market and to overseas markets.

Managers	Title	Age	Since
Li Jen Chen CEO	Chief Executive Officer	-	31/13/31

Members of the board	Title	Age	Since
Zuie Chin Huang CHM	Chairman	58	-
Li Jen Chen CEO	Chief Executive Officer	-	31/13/31
Jie Zhang BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	17,557,000	0	443,000 ( 2.523 %)	-

TriArm Therapeutics (Taiwan) Ltd.

27F-10 No. 99, Section 1, Xintai 5thn Road

221 01, New Taipei

http://www.humorigin.com.tw

address Humorigin Biotechnology Corp(6487)

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
HUMORIGIN BIOTECHNOLOGY CORP	-.--%	0
MODERNA, INC.	+35.72%	50.93B
IQVIA HOLDINGS INC.	-0.15%	42.12B
LONZA GROUP AG	+49.62%	42.05B
CELLTRION, INC.	-4.96%	29.18B
ICON PUBLIC LIMITED COMPANY	+12.54%	26.02B
ALNYLAM PHARMACEUTICALS, INC.	-22.55%	18.9B
BIO-TECHNE CORPORATION	+7.54%	13.21B
UNITED THERAPEUTICS CORPORATION	+24.70%	12.17B
MEDPACE HOLDINGS, INC.	+29.29%	12.16B

Other Biotechnology & Medical Research